Journal of Clinical Endocrinology & Metabolism, Vol 67, 882-887, Copyright © 1988 by Endocrine Society

ARTICLES

Regulation of the growth hormone-independent growth factor-binding protein in children

AM Cotterill, CT Cowell, RC Baxter, D McNeil and M Silinik
Ray Williams Institute of Endocrinology, Royal Alexandra Hospital for Children, Camperdown, New South Wales, Australia.

Regulation of the diurnal variation of the GH-independent insulin-like growth factor-binding protein (BP-28) was studied in 53 children who underwent various investigations for possible endocrine abnormalities. The plasma BP-28 levels increased 12-fold from 8 +/- 2 (+/-SE) micrograms/L at 2100 h to a peak level of 109 +/- 15 micrograms/L between 0600 and 0800 h. This rise was inversely related to plasma insulin levels and was unrelated to plasma cortisol levels. The overnight rise of plasma BP-28 was significantly altered in children who ate a light meal at 0130 h; in them BP-28 levels started to fall after 0300 h, reached nadir levels at 0400 h, began to rise again by 0700 h, and returned to control levels by 0800 h. Such changes did not occur in children given water alone. From the peak early morning level, plasma BP-28 fell to basal levels in children given oral glucose at 0800 h; the t1/2 of the fall was 55 +/- 9 (+/-SE) min. In children who continued to fast, plasma BP-28 did not fall but, rather, increased from 144 +/- 12 micrograms/L at 0800 h after 10 h of fasting to 239 +/- 30 micrograms/L by 1600 h. The induction of hypoglycemia by insulin given at 0945 h after an overnight fast caused a similar but more rapid rise in plasma BP-28 to 668 +/- 317 micrograms/L (range, 208-1763 micrograms/L) by 1230 h. These results suggest that the diurnal variation of plasma BP-28 concentrations in children is not due to an intrinsic rhythm, but is regulated by the metabolic status of the child.

This article has been cited by other articles:

				M. Shimizu, B. R Beckman, A. Hara, and W. W Dickhoff Measurement of circulating salmon IGF binding protein-1: assay development, response to feeding ration and temperature, and relation to growth parameters J. Endocrinol., January 1, 2006; 188(1): 101 - 110. [Abstract] [Full Text] [PDF]

				D. Mesotten, P. J. D. Delhanty, F. Vanderhoydonc, K. V. Hardman, F. Weekers, R. C. Baxter, and G. van den Berghe Regulation of Insulin-Like Growth Factor Binding Protein-1 during Protracted Critical Illness J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5516 - 5523. [Abstract] [Full Text] [PDF]

				T. J. Maures and C. Duan Structure, Developmental Expression, and Physiological Regulation of Zebrafish IGF Binding Protein-1 Endocrinology, July 1, 2002; 143(7): 2722 - 2731. [Abstract] [Full Text] [PDF]

				L. E. L. Katz, D. D. DeLeon, H. Zhao, and A. F. Jawad Free and Total Insulin-Like Growth Factor (IGF)-I Levels Decline during Fasting: Relationships with Insulin and IGF-Binding Protein-1 J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2978 - 2983. [Abstract] [Full Text] [PDF]

				E Charmandari, C G D Brook, and P C Hindmarsh Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Arch. Dis. Child., April 1, 2002; 86(4): 266 - 269. [Abstract] [Full Text] [PDF]

				W. S. Cutfield, P. L. Hofman, M. Vickers, B. Breier, W. F. Blum, and E. M. Robinson IGFs and Binding Proteins in Short Children with Intrauterine Growth Retardation J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 235 - 239. [Abstract] [Full Text] [PDF]

				T. Matsukawa, Y. Inoue, Y. Oishi, H. Kato, and T. Noguchi Up-Regulation of Upstream Stimulatory Factors by Protein Malnutrition and Its Possible Role in Regulation of the IGF-Binding Protein-1 Gene Endocrinology, November 1, 2001; 142(11): 4643 - 4651. [Abstract] [Full Text] [PDF]

				S. Guo, G. Rena, S. Cichy, X. He, P. Cohen, and T. Unterman Phosphorylation of Serine 256 by Protein Kinase B Disrupts Transactivation by FKHR and Mediates Effects of Insulin on Insulin-like Growth Factor-binding Protein-1 Promoter Activity through a Conserved Insulin Response Sequence J. Biol. Chem., June 11, 1999; 274(24): 17184 - 17192. [Abstract] [Full Text] [PDF]

				R. C. Baxter Comment--Do Glucocorticoids Mediate the Hypoglycemia-Induced Rise in Insulin-Like Growth Factor Binding Protein-1? J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2259 - 2261. [Full Text]

				M. S. Gill, A. A. Toogood, J. Jones, P. E. Clayton, and S. M. Shalet Serum Leptin Response to the Acute and Chronic Administration of Growth Hormone (GH) to Elderly Subjects with GH Deficiency J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1288 - 1295. [Abstract] [Full Text]

				B M D Brennan, M Gill, L Pennells, O B Eden, A G Thomas, and P E Clayton Insulin-like growth factor I, IGF binding protein 3, and IGFBP protease activity: relation to anthropometric indices in solid tumours or leukaemia Arch. Dis. Child., March 1, 1999; 80(3): 226 - 230. [Abstract] [Full Text]

				L. E. Levitt Katz, M. S. Satin-Smith, P. Collett-Solberg, L. Baker, C. A. Stanley, and P. Cohen Dual Regulation of Insulin-Like Growth Factor Binding Protein-1 Levels by Insulin and Cortisol during Fasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4426 - 4430. [Abstract] [Full Text]

				S. H. Travers, J. I. Labarta, S. E. Gargosky, R. G. Rosenfeld, B. W. Jeffers, and R. H. Eckel Insulin-Like Growth Factor Binding Protein-I Levels Are Strongly Associated with Insulin Sensitivity and Obesity in Early Pubertal Children J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1935 - 1939. [Abstract] [Full Text]

				E. Fernqvist-Forbes, A. Hilding, K. Ekberg, and K. Brismar Influence of Circulating Epinephrine and Norepinephrine on Insulin-Like Growth Factor Binding Protein-1 in Humans J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2677 - 2680. [Abstract] [Full Text] [PDF]